| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.26 | 0.2 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.078 | 0.2 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.23 | 0.2 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.2 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |